mRNA |
BRD-K13999467 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
-0.023 |
0.5 |
mRNA |
selumetinib:piperlongumine (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
YL54 |
CTRPv2 |
pan-cancer |
AAC |
-0.028 |
0.5 |
mRNA |
BRD-K86535717 |
CTRPv2 |
pan-cancer |
AAC |
0.054 |
0.5 |
mRNA |
FSC231 |
CTRPv2 |
pan-cancer |
AAC |
-0.052 |
0.5 |
mRNA |
BIBR-1532 |
CTRPv2 |
pan-cancer |
AAC |
-0.026 |
0.5 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |
mRNA |
BRD-K75293299 |
CTRPv2 |
pan-cancer |
AAC |
0.052 |
0.5 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.025 |
0.5 |